首页> 外国专利> MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES

MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES

机译:抗可溶性TNF-α受体p55和p75的单克隆抗体以及抗TNF-α及其类似物

摘要

The present invention belongs to the field of pharmaceutical industry and relates to novel monoclonal antibodies and fragments thereof which are bound to the available surface of a human recombinant TNF-α, TNF-α analogues and TNF-α soluble receptors p55 and p75. Further, the invention relates to stable hybridoma cell lines, which lines are capable of producing such monoclonal antibodies, to a process for the preparation thereof and to pharmaceutical preparations containing them. The invention also relates to a method for the quantitative determination of human TNF-α, free or complexed with soluble TNF-α receptors p55 and p75, and to a kit used therefor. By hitherto disclosed monoclonal antibodies and reagents developed therefrom, it has not been possible to simultaneously determine free TNF-α and its soluble receptors p55 and p75 as well as complexes thereof. Another object of the invention is also the TNF-α analogue TNF-α Cys95His107His108Cys148, which in a complex with TNF-α soluble receptors, is used as an antigen for immunization of mice.
机译:本发明属于制药工业领域,涉及与人重组TNF-α,TNF-α类似物和TNF-α可溶性受体p55和p75的可用表面结合的新型单克隆抗体及其片段。另外,本发明涉及稳定的杂交瘤细胞系,该系能够产生这种单克隆抗体,涉及其制备方法以及含有它们的药物制剂。本发明还涉及定量测定游离或与可溶性TNF-α受体p55和p75复合的人TNF-α的方法,以及用于该试剂盒的试剂盒。通过迄今为止公开的单克隆抗体和由其开发的试剂,不可能同时测定游离TNF-α及其可溶性受体p55和p75及其复合物。本发明的另一个目的是TNF-α类似物TNF-αCys95His107His108Cys148,其与TNF-α可溶性受体复合,用作抗原来免疫小鼠。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号